The starting material is the product of a chemical strategy the same group pioneered in 2023. Rather than introducing transcription factors or relying on rare, transient subpopulations of embryonic stem cells, the team used a defined cocktail of small molecules to push mouse cells into a state that molecularly mirrors the two-cell embryo, the earliest stage at which the zygotic genome has just switched on. Single-cell RNA sequencing of the resulting ciTotiSCs revealed strong activation of both maternal and zygotic genome activation programs, hallmarks of genuine totipotency, alongside suppression of the pluripotency networks that define conventional embryonic stem cells. In other words, the cells were not merely pluripotent, capable of making embryonic tissues, but appeared to carry the broader potential that includes the extraembryonic lineages needed to build a placenta and yolk sac.

Converting that molecular resemblance into actual embryogenesis, however, demanded a carefully choreographed culture environment. The researchers aggregated ciTotiSCs in microwells and exposed them to a sequence of media conditions, including combinations of small molecules and growth factors such as A83-01, CHIR, LPA, EGF and BMP4, followed by heparin and FGF4. Within days, the aggregates formed blastocyst-like structures that closely resembled natural blastocysts in both morphology and lineage segregation. Immunostaining showed the expected spatial organization: SOX2- and OCT4-positive cells forming the inner cell mass, GATA3-positive cells forming the trophectoderm, and GATA6- and SOX17-positive cells marking the primitive endoderm. Even the squamous, stretched morphology of natural trophectoderm cells was reproduced, and the models displayed rhythmic cycles of blastocoel cavity inflation and deflation reminiscent of living blastocysts.

What followed is arguably the most striking part of the study. Under conditions supporting continuous ex utero development, the ciTotiSC-derived embryo models, or ciToti-EMs, progressed through peri-implantation stages, forming egg cylinder-shaped structures with a pro-amniotic cavity enclosed by SOX2-positive epiblast cells showing apical F-actin and ZO-1 enrichment, precisely as in natural embryos. The models then segregated their embryonic and extraembryonic compartments, developed visceral endoderm and parietal endoderm, and initiated gastrulation, marked by the appearance of Brachyury- and FOXA2-positive cells at a primitive streak. By the equivalent of embryonic day 8.5, the models displayed an anterior-posterior axis, neural folds expressing PAX6, somites marked by HOXB4, a hindgut, and regional specification along both the anterior-posterior and dorsal-ventral axes.

The extraembryonic lineages, often the weak point of synthetic embryo models, were also faithfully generated. Single-cell transcriptomics identified amnion, allantois, yolk sac and parietal endoderm populations in the day-8.5-equivalent models, and Pearson correlation analysis showed transcriptome-wide similarity between these compartments and their natural counterparts. Primordial germ cells emerged as well, identified by co-expression of BLIMP1 and STELLA, and could be tracked migrating through the tail bud and hindgut regions of the models. When dissociated and expanded on feeder layers, these cells showed the epigenetic reprogramming characteristic of the germline, including reduced H3K9me2 and elevated H3K27me3, and progressed toward maturation markers such as DAZL and DDX4. This suggests the ciToti-EM system could become a scalable source of germline cells for studying fertility and heredity.

Blood formation, another milestone of mid-gestation development, proceeded with remarkable fidelity. The models generated vascular endothelium, erythroblasts, hematopoietic epithelia and macrophage populations that clustered alongside their natural E8.5 equivalents in integrated single-cell analyses. Erythroblasts collected from the models were nucleated, as expected for primitive mouse blood, and colony-forming unit assays confirmed that the models contained functional hematopoietic progenitors capable of generating erythroid and macrophage colonies in vitro. The supervised comparison framework the team built, which trains a logistic regression classifier on an annotated atlas of natural embryo data and scores how well each model’s cell types match reference lineages, placed the ciToti-EMs ahead of previously published embryo models across most lineages and stages examined.

Perhaps the most visually compelling result came from extended culture. The ciToti-EMs developed beating heart-like structures, and live imaging captured peristaltic-like contractions in earlier models followed by coordinated, chamber-specific rhythmic beating in later ones. Histological and immunofluorescent analyses of the cardiac tissue revealed a thin epicardial layer, trabeculated myocardium, and regionalized expression of atrial, ventricular and atrioventricular canal markers, closely mirroring natural E10.5 hearts. Single-cell profiling distinguished first heart field, second heart field, atrial and ventricular cardiomyocytes, outflow tract cells, cardiac neural crest cells and endothelial cells, and even identified macrophages and erythroblasts within the cardiac chambers, as seen in natural embryos at this stage.

The implications reach well beyond mouse developmental biology. A model built entirely from a single, chemically induced cell type sidesteps the ethical and practical constraints of using natural embryos or mixtures of multiple stem cell lines, and offers a reproducible, scalable platform for dissecting the molecular logic of early mammalian development. Because the entire process begins with small molecules rather than genetic manipulation, it also hints at a future in which multicellular organisms, or at least substantial portions of them, could be generated from ordinary somatic cells without ever passing through a fertilized egg. The authors are careful to frame the work as a model system, and the models, while extraordinarily complete, are not viable organisms. Nonetheless, the demonstration that one induced cell type can autonomously recapitulate the full spectrum of early mouse embryogenesis marks a watershed for synthetic embryology.

Significant questions remain. The efficiency of progressing from starting aggregates to late-stage models is still modest, and the extrapolated developmental efficiencies suggest substantial attrition at each transition. Whether the same chemical strategy can be adapted to human cells, and what regulatory frameworks should govern such models, are debates that will intensify. For now, the ciToti-EM system gives researchers something they have long lacked: a self-contained, tractable window into mammalian development from the two-cell state to the beating heart, one that can be perturbed, imaged and sequenced at every step. As embryo models grow ever more faithful, the line between modeling life and initiating it grows thinner, and this study moves that line decisively forward.

Subject of Research: Modelling mouse embryogenesis from chemically induced totipotent stem cells

Article Title: Modelling mouse embryogenesis from chemically induced totipotent stem cells

Article References: Modelling mouse embryogenesis from chemically induced totipotent stem cells. (n.d.). https://doi.org/10.1038/s41586-026-11164-5

Image Credits: AI Generated

DOI: 10.1038/s41586-026-11164-5

Keywords: totipotent stem cells, embryo models, mouse embryogenesis, gastrulation, synthetic embryos, ciTotiSCs, blastocyst, cardiogenesis, hematopoiesis, primordial germ cells, single-cell RNA sequencing, developmental biology

The research, published in Cell Systems, introduces a computational framework that systematically evaluates how faithfully different blastoid-generation methods reproduce the cell types and developmental processes seen in natural human embryos. Led by Associate Professor Pengyi Yang, an ARC Future Fellow in the School of Mathematics and Statistics and Unit Head of Computational Systems Biology at the Children’s Medical Research Institute, the study set out to solve a problem that has hampered the field since its inception. According to Yang, human embryo models hold enormous potential for studying the earliest days of development, but until now there has been no consistent way to assess how accurately these models reflect genuine human biology. The new framework gives researchers an objective yardstick against which every future model can be measured.

At the heart of the work lies one of the most comprehensive reference maps of early human embryo development ever assembled. The team combined and harmonised more than 14,000 single-cell transcriptomes, the complete sets of RNA molecules within individual cells, drawn from human embryos spanning key stages of development. Single-cell transcriptomics allows scientists to read out, cell by cell, which genes are active at any given moment, effectively providing a molecular fingerprint of cellular identity. By integrating thousands of these profiles, the researchers constructed a detailed atlas of how cells normally differentiate and organise themselves during the days immediately before and after implantation, the critical window when the embryo attaches to the uterine wall and its foundational lineages take shape.

With this reference map in hand, the team turned to the models themselves. They evaluated four widely used blastoid-generation protocols developed by international research groups, comparing each against the natural benchmark. Crucially, the evaluation went far beyond morphology. Rather than asking whether the models simply resembled embryos under a microscope, the researchers examined their molecular identities, developmental timing, lineage structure and other biological characteristics. This distinction matters because appearance can be deceptive. A structure may adopt the right shape while its constituent cells follow molecular programmes that diverge substantially from those of a genuine blastocyst, the hollow ball of cells that forms roughly five to seven days after fertilisation.

The results revealed striking differences between the four approaches. Some blastoid models reproduced all three major cell lineages of a natural human blastocyst relatively well, capturing the essential cellular cast of early development. Others failed to accurately represent certain cell types or contained large numbers of cells that could not be confidently matched to any known embryonic state, suggesting that the models were producing cells whose identities were unclear or possibly artefactual. Notably, no single model perfectly replicated a natural human blastocyst. The finding does not diminish the value of the models, Yang emphasised, but it does impose discipline on how they are used. The encouraging news, he noted, is that some models capture important aspects of early embryonic development relatively well, although each has limitations.

The cautionary side of the message is equally important. Yang stressed that current models are not biologically equivalent to real human embryos, and that researchers need to be careful about the conclusions they draw from them. This warning carries real weight for a field in which blastoids are increasingly used to probe questions about implantation, early lineage specification and the origins of developmental disorders. If a model misrepresents a particular cell type or mis-times a developmental transition, findings built on that model could mislead rather than illuminate. The benchmark provides a way to distinguish which claims a given model can legitimately support and which lie beyond its current fidelity, helping to keep scientific claims grounded in what the systems can actually deliver.

The significance of the work extends beyond the immediate findings. Blastoids exist precisely because studying natural human embryos is constrained by both technical hurdles and ethical limits. International guidelines restrict the culture of human embryos beyond fourteen days, and the supply of donated embryos for research is limited. Stem-cell-derived models offer a scalable alternative, but their legitimacy depends entirely on how well they mirror the real thing. By providing a standardised, quantitative benchmark, the Sydney framework transforms what has often been a qualitative and contested judgement into a measurable comparison. The researchers hope this will allow future models to be improved more rapidly and evaluated more rigorously, accelerating a cycle of refinement across laboratories worldwide.

In a move likely to shape the field’s trajectory, the team has made its reference datasets and benchmarking tools publicly available. Any laboratory developing a new blastoid protocol can now test its products against the same molecular standards used in the study, creating a common language for model quality across the international research community. This kind of shared infrastructure is often what turns a promising technique into a reliable one, and it echoes the impact of earlier reference atlases that transformed fields such as genomics and single-cell biology. If we are going to use these systems to answer important biological questions, Yang said, we first need to know what they can reliably tell us. His team’s work, he added, provides a roadmap for improving embryo models and ensuring that scientific claims remain grounded in what the models can actually support.

The study, authored by Long, S. and colleagues under the title Systematic transcriptomic evaluation of blastoid models of early human development, was supported by a National Health and Medical Research Council Investigator Grant and a Metcalf Prize for Stem Cell Research awarded to Yang, while collaborator Raja Jothi was supported by the Intramural Research Program of the National Institutes of Health and the National Institute of Environmental Health Sciences in the United States. The authors declare no competing interests. As embryo models continue to evolve, the framework offers the field something it has long lacked: a way to tell, with molecular precision, how close lab-grown versions of early human life have come to the genuine article, and how much further they still have to go.

Subject of Research: Computational benchmarking of stem-cell-derived blastoid models against natural early human embryo development

Article Title: Scientists develop ‘reality check’ for lab-grown human embryo models

Article References: Scientists develop ‘reality check’ for lab-grown human embryo models. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: blastoids, embryo models, stem cells, single-cell transcriptomics, early human development, benchmarking, University of Sydney, Cell Systems, developmental biology, reference map, implantation, research ethics

The significance of the achievement lies in what these cells represent. In mammals, development begins when a sperm fertilizes an oocyte, creating a zygote. In humans, that single cell remains transcriptionally silent, meaning its genome is largely switched off, until the major wave of zygotic genome activation, or ZGA, occurs around the eight-cell stage. At that point, and in the morula cells that follow, the embryo’s cells are totipotent: they possess the extraordinary capacity to give rise to an entire individual, including both the embryo proper and the supporting tissues. Capturing that fleeting state in a dish has long been one of the most coveted goals in stem cell science.

The obstacle has always been access. Human embryos are ethically fraught as research material, and the supply of early cleavage-stage embryos available for study is vanishingly small. As a result, scientists’ understanding of human totipotency remains rudimentary compared with their deep knowledge of pluripotency, the more restricted capacity of embryonic stem cells to form any tissue of the body but not a whole organism. The new protocol addresses that bottleneck directly by offering a controllable, transgene-free method to produce cells that mimic the eight-cell stage without using embryos at all.

At the heart of the method is a novel culture medium formulated by the team, containing specific chemical compounds and cytokines that push pluripotent stem cells into the eight-cell embryo-like state. The researchers describe two routes to get there. The first is a stepwise approach that moves cells from a primed pluripotent state into a naive state and then onward to 8CLCs, a journey that takes only five days starting from naive pluripotent stem cells. The second is a direct conversion from primed pluripotent stem cells, which requires roughly seven days. Both routes yield cells that can be isolated and characterized using the techniques laid out in the protocol.

The technical details matter enormously for reproducibility, which is precisely why the team chose to publish in a protocols journal. The paper walks readers through the induction of the cells, their isolation from the surrounding culture, and their characterization at multiple levels. Characterization includes immunofluorescence imaging, the use of a TPRX1-EGFP reporter line that fluoresces when the cells enter the eight-cell-like state, and single-cell RNA sequencing to profile gene expression cell by cell. The published figures document the generation of naive pluripotent stem cells on feeder layers and on extracellular matrix, the stepwise and direct induction of 8CLCs, and transcriptomic analyses that compare the resulting cells with natural human embryo data.

Crucially, the resulting 8CLCs exhibit transcriptional and epigenetic features resembling those of genuine human eight-cell embryo cells. In plain terms, the cells have switched on many of the same genes that flicker to life during zygotic genome activation, and their epigenetic markings, the chemical modifications that control gene activity without altering DNA sequence, have shifted toward the embryonic configuration. The authors note that their 8CLCs share similarities with eight-cell-like cells generated by other methods, but there are differences in the expression levels of certain totipotency genes and transposable elements, ancient viral remnants in the genome that are famously reawakened during early development. Those differences give researchers an opportunity to compare approaches and refine the models further.

The broader scientific context helps explain why this protocol is generating such excitement. Work in mice had already shown that embryonic stem cell potency fluctuates with the activity of endogenous retroviruses, and that factors such as DUX and the Zscan4 family can activate cleavage-stage gene programs and drive cells into a totipotent two-cell-like state. Subsequent studies identified regulators including Dppa2 and Dppa4, NELFA, and retinoic acid signaling as players in the totipotency window, and chemical cocktails were eventually shown to induce totipotent-like stem cells in mouse systems. For humans, parallel efforts produced 8C-like cells that capture the zygotic genome activation program in vitro, and transient expression of DUX4 was shown to induce a blastomere-like expression program. The new protocol consolidates this knowledge into a practical, transgene-free workflow for human cells.

The team behind the work draws on a strong track record. The protocol builds on the group’s earlier primary research paper, published in Nature in 2022, in which they first reported rolling back human pluripotent stem cells to an eight-cell embryo-like stage. The data discussed in the protocol were generated as part of that study, and representative results are provided alongside the methods. The authors expect that an individual with roughly one year of experience working with human pluripotent stem cell culture would be able to carry out the procedure, a deliberately accessible bar that should allow laboratories around the world to adopt the technique without exotic equipment or rare expertise.

The implications stretch across several fields. For basic developmental biology, 8CLCs offer an ethically unburdened and materially abundant model for dissecting the molecular events surrounding zygotic genome activation, one of the most fundamental transitions in human life. For reproductive medicine, a deeper understanding of early embryogenesis could illuminate causes of infertility and early pregnancy loss, which often trace back to failures in these first few days of development. For regenerative medicine, totipotent-like cells represent the theoretical starting point for generating any cell type in the body, and possibly extraembryonic lineages as well, from a standardized laboratory source. The work also connects to a rapidly expanding ecosystem of embryo models, including blastoids and gastruloids derived from stem cells, which together are assembling a laboratory-based picture of human development from fertilization through implantation and early organogenesis.

As with any powerful technology, the advance arrives with responsibilities. The authors have filed patent applications covering the protocols for human 8CLC generation and characterization, reflecting both the scientific and commercial stakes of the method. Researchers and ethicists will continue to debate the appropriate boundaries for embryo models, even ones that cannot and are not intended to develop into organisms. What is clear is that the availability of a reproducible, transgene-free protocol lowers the barrier to entry for studying the earliest chapter of human development, and that the cells it produces, glowing green when they switch on the right genes and transcribing the ancient program of the eight-cell embryo, will become a standard tool in laboratories probing the origins of human life.

Subject of Research: A protocol for generating totipotent eight-cell embryo-like cells from human pluripotent stem cells to model zygotic genome activation

Article Title: Generation of eight-cell embryo-like cells from human pluripotent stem cells

Article References: Mazid, M. A., Li, Y., Zhao, M., Fu, L., Liu, H., Jiang, Y., Jia, W., Lai, J., Li, J., Li, H., Saeed, B. J., Manzoor, A., Luo, Z., Lai, Y., Wu, L., Zou, Y., Ariyachet, C., Ward, C., Liu, C., … Li, W. (2026). Generation of eight-cell embryo-like cells from human pluripotent stem cells. Nature Protocols. https://doi.org/10.1038/s41596-026-01414-1

Image Credits: AI Generated

DOI: 10.1038/s41596-026-01414-1

Keywords: eight-cell embryo-like cells, human pluripotent stem cells, totipotency, zygotic genome activation, stem cell reprogramming, Nature Protocols, early embryogenesis, naive pluripotency, single-cell RNA sequencing, transgene-free induction, embryo models, developmental biology